Ten years after the original discovery of this potent molecule, VEGF still holds great therapeutic promise. But who said that it would be easy? Lee, R.J. et al. VEGF gene delivery to myocardium ...

The ability of tumours to induce new blood-vessel formation has been a major focus of cancer research over the past few decades, and vascular endothelial growth factor (VEGF) is now known to be ...

Summit Therapeutics is making strides with ivonescimab, but upcoming trial results and financial challenges suggest caution. Check out why SMMT stock is a hold.

The drug also showed potential efficacy in patients who failed to optimally respond to anti-VEGF treatment. Results of a phase IIb trial comparing UBX1325 to anti-VEGF therapy are expected later ...

Retinal pigment epithelial detachment is associated with neovascular age-related macular degeneration in 30% to 80% of cases, according to the literature.It is often difficult to treat, requires a ...